Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The oligonucleotide therapy market is forecasted to achieve exponential growth in the coming few years with a forecast CAGR (compound annual growth rate) of 14%, as per The Business Research Company’s market report!

Read More On The Oligonucleotide Therapy Market Report 2022 – https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

The Oligonucleotide Therapy Market Size In 2022 And Forecast

The global oligonucleotide therapy market is expected to reach from $0.98 billion in 2021 to $1.10 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The oligonucleotide therapy market is expected to reach $1.86 billion in 2026 at a CAGR of 14.0%.

The oligonucleotide therapy market consists of sales of oligonucleotide therapy-related services by entities (organizations, sole traders and partnerships) that manufacture oligonucleotide therapy products.

Request for A Sample Of The Global Oligonucleotide Therapy Market Report:

 https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

Rise In The Number Of Cancer Cases Globally Is Driving The Growth Of The Oligonucleotide Therapy Market

According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the oligonucleotide therapy market over the forthcoming years.

Competitive Landscape And The Regional Analysis Of The Oligonucleotide Therapy Market

Major players in the oligonucleotide therapy market are Alnylam Pharmaceuticals Inc., Biogen Inc., Dynavax Technologies Corp., Ionis Pharmaceuticals Inc., Merck & Co. Inc., Miragen Therapeutics Inc., PCI Biotech Holdings ASA, Sarepta Therapeutics Inc., Jazz Pharmaceuticals and Bausch & Lomb.

The Oligonucleotide Therapy Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the oligonucleotide therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the oligonucleotide therapy market.

Remodel The Design Of Therapy – A Key Trend In The Oligonucleotide Therapy Market

The developers and providers of the oligonucleotide therapy market are investing in research and development to remodel the design of therapy to reduce its side effects on patients. The new and innovative oligonucleotides allow precision medicine approaches and can be designed to selectively target any gene with minimal side effects. It also helps in targeting patient-specific sequences that are causative of rare diseases.

Oligonucleotide Therapy Market Segmentation By The Business Research Company

1) By Type: Antisense Oligonucleotide, Aptamer, Other

2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others

3) By End-User: Hospitals, Research Institutes

Here Are Some Reports Related To The Oligonucleotide Therapy Market –

Drugs For Immunotherapy Global Market Report 2022

Cell Therapy Global Market Report 2022

Gene Therapy Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found This Article Helpful? Share It On: